AnPac Bio-Medical Science Co Ltd - ADR (ANPC) stock is lower by -32.05% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives ANPC stock a score of 10 out of a possible 100.
That rank is primarily influenced by a fundamental score of 0. ANPC stock has a mean target price of 8. This means analysts expect the stock to gain 41.84% over the next 12 months. ANPC's rank also includes a short-term technical score of 8. The long-term technical score for ANPC is 23.
What's Happening with ANPC Stock Today
AnPac Bio-Medical Science Co Ltd - ADR (ANPC) stock has risen 3.87% while the S&P 500 has gained 0.19% as of 2:10 PM on Tuesday, Apr 13. ANPC has gained $0.21 from the previous closing price of $5.43 on volume of 62,816 shares. Over the past year the S&P 500 is up 49.77% while ANPC is lower by -32.05%. ANPC lost -$1.28 per share in the over the last 12 months.
